CUDC-907 mesylate is a small molecule inhibitor of histone deacetylase and PI3 kinase developed by Curis. It is investigated in clinical trials for the treatment of relapsed or refractory lymphomas, thyroid cancer, multiple myeloma, breast cancer and other malignancies.
Molecular Weight:
604.66
CAS Number:
[1401998-36-4]
Formula:
C24H28N8O7S2
Target:
Others|||HDAC|||PI3K|||Apoptosis
T70759
* VAT and and shipping costs not included. Errors and price changes excepted